There is a lot of discussion ongoing in the DMD community about biomarkers and surrogate endpoints as was pointed out by patient representatives during an ENMC meeting on biomarkers for DMD (Jan 24–26 2014, Naarden, the Netherlands). On their request this document will explain what biomarkers are and will address questions about biomarkers and surrogate endpoints.
Biomarkers and surrogate endpoints in Duchenne: meeting report
FERLINI, Alessandra;
2014
Abstract
There is a lot of discussion ongoing in the DMD community about biomarkers and surrogate endpoints as was pointed out by patient representatives during an ENMC meeting on biomarkers for DMD (Jan 24–26 2014, Naarden, the Netherlands). On their request this document will explain what biomarkers are and will address questions about biomarkers and surrogate endpoints.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
